文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

黑人及白人癌症患者COVID-19结局的种族差异

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
PubMed 文献 · JAMA Netw Open · 2022-03-01
一句话结论在癌症合并COVID-19患者中,黑人患者病情更重、COVID-19严重程度更高(加权OR 1.21,95%CI 1.11-1.33)。

该回顾性队列研究利用COVID-19与癌症联盟登记处2020年3月17日至2020年11月18日的数据,比较黑人及非西班牙裔白人癌症患者COVID-19的临床特征与结局。共纳入3506例患者,黑人1068例(30%),白人2438例(70%)。黑人患者肥胖、糖尿病、肾病等基础合并症比例更高,但癌症类型、癌症状态及抗癌治疗分布相似,其就诊时病情更重,COVID-19严重程度显著更差(未加权OR 1.34,95%CI 1.15-1.58;加权OR 1.21,95%CI 1.11-1.33)。作者认为,应在结构性种族主义的因果框架下理解并解决种族不平等,以减轻黑人患者中COVID-19和癌症等疾病的过重负担。

要点

  • 黑人癌症患者COVID-19严重程度更高:未加权OR 1.34(95%CI 1.15-1.58),加权OR 1.21(95%CI 1.11-1.33)。
  • 黑人患者基础合并症更多:肥胖45% vs 38%,糖尿病38% vs 24%,肾病23% vs 16%。
  • 两组癌症类型、癌症状态及抗癌治疗分布相似,但黑人患者就诊时病情更重。
  • 主要结局为5级序贯量表,包括住院、ICU入住、机械通气和全因死亡。

适用人群与场景

  • COVID-19与癌症联盟登记处收录的癌症合并COVID-19患者,数据收集时间为2020年3月17日至2020年11月18日。
  • 纳入黑人及非西班牙裔白人患者,共3506例(黑人1068例,白人2438例)。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用COVID-19与癌症联盟登记处数据,数据分析时间为2020年12月至2021年2月。
  • 人群:3506例患者,女性1768例(50%),中位年龄67岁(IQR 58-77);黑人1068例(30%),白人2438例(70%)。
  • 主要终点:5级序贯量表(住院、ICU入住、机械通气、全因死亡);黑人患者COVID-19严重程度显著更差,未加权OR 1.34(95%CI 1.15-1.58),加权OR 1.21(95%CI 1.11-1.33)。
  • 合并症:肥胖黑人480例(45%)vs 白人925例(38%);糖尿病黑人411例(38%)vs 白人574例(24%);肾病黑人248例(23%)vs 白人392例(16%)。
  • 癌症类型、癌症状态及COVID-19诊断时抗癌治疗分布在两组间相似,黑人患者就诊时病情更重。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现提示黑人癌症患者较白人患者经历更差的COVID-19结局。
  • 作者认为,在结构性种族主义的因果框架内理解和解决种族不平等,对于减轻黑人患者中COVID-19和癌症等疾病的过重负担至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Non-Hispanic Black individuals experience a higher burden of COVID-19 than the general population; hence, there is an urgent need to characterize the unique clinical course and outcomes of COVID-19 in Black patients with cancer.

OBJECTIVE: To investigate racial disparities in severity of COVID-19 presentation, clinical complications, and outcomes between Black patients and non-Hispanic White patients with cancer and COVID-19.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from the COVID-19 and Cancer Consortium registry from March 17, 2020, to November 18, 2020, to examine the clinical characteristics and outcomes of COVID-19 in Black patients with cancer. Data analysis was performed from December 2020 to February 2021.

EXPOSURES: Black and White race recorded in patient's electronic health record.

MAIN OUTCOMES AND MEASURES: An a priori 5-level ordinal scale including hospitalization intensive care unit admission, mechanical ventilation, and all-cause death.

RESULTS: Among 3506 included patients (1768 women [50%]; median [IQR] age, 67 [58-77] years), 1068 (30%) were Black and 2438 (70%) were White. Black patients had higher rates of preexisting comorbidities compared with White patients, including obesity (480 Black patients [45%] vs 925 White patients [38%]), diabetes (411 Black patients [38%] vs 574 White patients [24%]), and kidney disease (248 Black patients [23%] vs 392 White patients [16%]). Despite the similar distribution of cancer type, cancer status, and anticancer therapy at the time of COVID-19 diagnosis, Black patients presented with worse illness and had significantly worse COVID-19 severity (unweighted odds ratio, 1.34 [95% CI, 1.15-1.58]; weighted odds ratio, 1.21 [95% CI, 1.11-1.33]).

CONCLUSIONS AND RELEVANCE: These findings suggest that Black patients with cancer experience worse COVID-19 outcomes compared with White patients. Understanding and addressing racial inequities within the causal framework of structural racism is essential to reduce the disproportionate burden of diseases, such as COVID-19 and cancer, in Black patients.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Fu J, Reid SA, French B, et al. Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer. JAMA Netw Open. 2022. PMID: 35344045. doi:10.1001/jamanetworkopen.2022.4304

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。